Serving leading biopharmaceutical companies globally:

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Daratumumab - Biologic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for daratumumab

Tradenames:	1
Patents:	12
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for daratumumab

Recent Clinical Trials for daratumumab

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Emory University	Phase 2
University of California, San Francisco	Phase 2
Ohio State University Comprehensive Cancer Center	Phase 2

See all daratumumab clinical trials

Pharmacology for daratumumab

Ingredient-type	Antibodies, Monoclonal
Mechanism of Action	CD38-directed Antibody Interactions

Patent Text Search: US Patents for daratumumab

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Janssen Biotech	DARZALEX	daratumumab	INJECTABLE;INJECTION	761036	001	2015-11-16	Start Trial	Excelse Bio, Inc. (Thousand Oaks, CA)	2031-10-28	RX	Orphan	search
Janssen Biotech	DARZALEX	daratumumab	INJECTABLE;INJECTION	761036	001	2015-11-16	Start Trial	ABBVIE STEMCENTRX LLC (North Chicago, IL)	2032-02-08	RX	Orphan	search
Janssen Biotech	DARZALEX	daratumumab	INJECTABLE;INJECTION	761036	001	2015-11-16	Start Trial	AbbVie Stemcentrx LLC (North Chicago, IL)	2033-02-08	RX	Orphan	search
Janssen Biotech	DARZALEX	daratumumab	INJECTABLE;INJECTION	761036	001	2015-11-16	Start Trial	Advenchen Pharmaceuticals, LLC (Moorpark, CA)	2035-05-04	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for daratumumab

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Mexico	2014005106	Start Trial
Canada	2999277	Start Trial
Australia	2016243120	Start Trial
China	107771078	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Baxter

AstraZeneca

Boehringer Ingelheim

Merck

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.